Literature DB >> 3539999

Thalassemic erythrocytes inhibit in vitro growth of Plasmodium falciparum.

C R Brockelman, B Wongsattayanont, P Tan-ariya, S Fucharoen.   

Abstract

Blood specimens from 100 thalassemic patients were screened in vitro for inhibitory effects on growth and multiplication of Plasmodium falciparum. The culture medium mixture designated REM consisted of 9 volumes of minimum essential medium (GIBCO Laboratories, Grand Island, N.Y.) and 1 volume of RPMI 1640 (GIBCO) supplemented with 10% heat-inactivated human serum. Parasite multiplication in erythrocytes containing normal hemoglobin cultured in RPMI or REM was similar. Significant reduction in parasite multiplication rates was observed in erythrocytes containing abnormal hemoglobin when these were cultured in REM. The degree of reduction in five types of thalassemic erythrocytes was in the following descending order: hemoglobin H disease with Hb Constant Spring, classical hemoglobin H disease, beta(0)-thalassemia-hemoglobin E in which blood harbored a high percentage of hemoglobin F-containing cells, beta (0)-thalassemia-hemoglobin E in which blood harbored few hemoglobin F-containing cells, and beta-thalassemia heterozygous variant.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3539999      PMCID: PMC265823          DOI: 10.1128/jcm.25.1.56-60.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  Genetics of red cells and susceptibility to malaria.

Authors:  L Luzzatto
Journal:  Blood       Date:  1979-11       Impact factor: 22.113

2.  The role of hemoglobins C, S, and Nbalt in the inhibition of malaria parasite development in vitro.

Authors:  M J Friedman; E F Roth; R L Nagel; W Trager
Journal:  Am J Trop Med Hyg       Date:  1979-09       Impact factor: 2.345

3.  Concentration from continuous culture of erythrocytes infected with trophozoites and schizonts of Plasmodium falciparum.

Authors:  J B Jensen
Journal:  Am J Trop Med Hyg       Date:  1978-11       Impact factor: 2.345

4.  Oxidant damage mediates variant red cell resistance to malaria.

Authors:  M J Friedman
Journal:  Nature       Date:  1979-07-19       Impact factor: 49.962

5.  Effects of foetal haemoglobin on susceptibility of red cells to Plasmodium falciparum.

Authors:  G Pasvol; D J Weatherall; R J Wilson
Journal:  Nature       Date:  1977-11-10       Impact factor: 49.962

6.  Haemoglobinopathies and malaria in Thailand: a comparison of morbidiy and mortality rates.

Authors:  M Kruatrachue; B Sriripanich; N Sadudee
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

7.  Haemoglobinopathies and malaria in Thailand.

Authors:  M Kruatrachue; M Bhaibulaya; K Klongkamnaunkarn; C Harinasuta
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

8.  Alpha- and beta-thalassemia in Thailand.

Authors:  P Wasi; S Na-Nakorn; S Pootrakul; M Sookanek; P Disthasongchan; V Panich; M Pornpatkul
Journal:  Ann N Y Acad Sci       Date:  1969-11-20       Impact factor: 5.691

9.  Drug sensitivity of plasmodium falciparum. An in-vitro microtechnique.

Authors:  K H Rieckmann; G H Campbell; L J Sax; J E Mrema
Journal:  Lancet       Date:  1978-01-07       Impact factor: 79.321

10.  Human malaria parasites in continuous culture.

Authors:  W Trager; J B Jensen
Journal:  Science       Date:  1976-08-20       Impact factor: 47.728

View more
  12 in total

1.  New antimalarial indolone-N-oxides, generating radical species, destabilize the host cell membrane at early stages of Plasmodium falciparum growth: role of band 3 tyrosine phosphorylation.

Authors:  Antonella Pantaleo; Emanuela Ferru; Rosa Vono; Giuliana Giribaldi; Omar Lobina; Françoise Nepveu; Hany Ibrahim; Jean-Pierre Nallet; Franco Carta; Franca Mannu; Proto Pippia; Estela Campanella; Philip S Low; Francesco Turrini
Journal:  Free Radic Biol Med       Date:  2011-11-15       Impact factor: 7.376

Review 2.  Oxidative stress in malaria; implications for prevention and therapy.

Authors:  N S Postma; E C Mommers; W M Eling; J Zuidema
Journal:  Pharm World Sci       Date:  1996-08

Review 3.  The role of the red blood cell in host defence against falciparum malaria: an expanding repertoire of evolutionary alterations.

Authors:  Morgan M Goheen; Susana Campino; Carla Cerami
Journal:  Br J Haematol       Date:  2017-08-23       Impact factor: 6.998

4.  Artemisinin Therapy for Malaria in Hemoglobinopathies: A Systematic Review.

Authors:  Sri Riyati Sugiarto; Brioni R Moore; Julie Makani; Timothy M E Davis
Journal:  Clin Infect Dis       Date:  2018-02-10       Impact factor: 9.079

Review 5.  Transgenic and mutant animal models to study mechanisms of protection of red cell genetic defects against malaria.

Authors:  H L Shear
Journal:  Experientia       Date:  1993-01-15

6.  Effects of thalassaemic serum on the in vitro development of the malarial parasite Plasmodium falciparum.

Authors:  B W Thanomsub; S Fucharoen; C R Brockelman; J Bhisutthibhan
Journal:  Parasitol Res       Date:  1989       Impact factor: 2.289

Review 7.  Oxidative stress and β-thalassemic erythroid cells behind the molecular defect.

Authors:  Lucia De Franceschi; Mariarita Bertoldi; Alessandro Matte; Sara Santos Franco; Antonella Pantaleo; Emanuela Ferru; Franco Turrini
Journal:  Oxid Med Cell Longev       Date:  2013-09-24       Impact factor: 6.543

Review 8.  Hemoglobinopathies: slicing the Gordian knot of Plasmodium falciparum malaria pathogenesis.

Authors:  Steve M Taylor; Carla Cerami; Rick M Fairhurst
Journal:  PLoS Pathog       Date:  2013-05-16       Impact factor: 6.823

Review 9.  The influence of host genetics on erythrocytes and malaria infection: is there therapeutic potential?

Authors:  Patrick M Lelliott; Brendan J McMorran; Simon J Foote; Gaetan Burgio
Journal:  Malar J       Date:  2015-07-29       Impact factor: 2.979

Review 10.  Erythropoiesis in Malaria Infections and Factors Modifying the Erythropoietic Response.

Authors:  Vrushali A Pathak; Kanjaksha Ghosh
Journal:  Anemia       Date:  2016-02-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.